JACOB MANDEL to Middle Aged
This is a "connection" page, showing publications JACOB MANDEL has written about Middle Aged.
Connection Strength
0.315
-
Hyperostosis frontalis interna diagnosed after a provoked seizure. BMJ Case Rep. 2020 Jul 01; 13(7).
Score: 0.044
-
Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol. 2019 Apr; 142(2):365-374.
Score: 0.040
-
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
Score: 0.033
-
Delayed imaging abnormalities of neuro-invasive West Nile virus in cancer patients. J Neurol Sci. 2015 Mar 15; 350(1-2):115-7.
Score: 0.031
-
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
Score: 0.030
-
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 Jan 16; 13(1):9.
Score: 0.015
-
The concurrence of multiple sclerosis and glioblastoma. Mult Scler Relat Disord. 2021 May; 50:102877.
Score: 0.012
-
Multicentric non-enhancing lesions in glioblastoma: A retrospective study. J Clin Neurosci. 2021 Mar; 85:20-26.
Score: 0.011
-
Height as a risk factor in meningioma: a study of 2 million Israeli adolescents. BMC Cancer. 2020 Aug 20; 20(1):786.
Score: 0.011
-
Gastrointestinal stromal tumor with intracranial metastasis: case presentation and systematic review of literature. BMC Cancer. 2019 Nov 15; 19(1):1119.
Score: 0.011
-
Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018 May; 137(3):601-609.
Score: 0.009
-
Spinal Dural Arteriovenous Fistula and Concomitant Intramedullary Spinal Lesion. Can J Neurol Sci. 2018 03; 45(2):238-239.
Score: 0.009
-
Intracranial Erdheim-Chester Disease Mimicking Parafalcine Meningioma: Report of Two Cases and Review of the Literature. World Neurosurg. 2018 Feb; 110:365-370.
Score: 0.009
-
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
Score: 0.009
-
Intraventricular Cavernomas of the Third Ventricle: Report of 2 Cases and a Systematic Review of the Literature. World Neurosurg. 2017 Sep; 105:935-943.e3.
Score: 0.009
-
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
Score: 0.008
-
Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
Score: 0.008
-
Venous thromboembolism (VTE) and glioblastoma. J Neurooncol. 2015 Aug; 124(1):87-94.
Score: 0.008
-
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
Score: 0.007